Edan Instruments, Inc. (SHE:300206)

Market Cap	7.94B +6.8%
Revenue (ttm)	2.00B +9.0%
Net Income	305.64M +88.5%
EPS	0.53 +88.5%
Shares Out	579.66M
PE Ratio	25.96
Forward PE	n/a
Dividend	0.21 (1.58%)
Ex-Dividend Date	May 27, 2025

Volume	17,622,800
Average Volume	10,234,202
Open	13.66
Previous Close	13.08
Day's Range	13.17 - 13.78
52-Week Range	9.55 - 16.80
Beta	0.55
RSI	38.81
Earnings Date	Mar 31, 2026

About Edan Instruments

Edan Instruments, Inc. engages in the research, development, manufacture, and service of medical electronic equipment and in vitro diagnostic products in China and internationally. The company offers ECG products, including resting ECG, stress test, holter, wireless solution, and ECG workstation products; patient monitoring systems, such as modular and compact patient monitor, vital signs, and telemetry and IT products; and obstetrics and gynecology products comprising fetal and maternal monitoring systems, fetal telemetry systems, ultrasonic d...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1995
• Employees: 2,546
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300206

Financial Performance

In 2025, Edan Instruments's revenue was 2.00 billion, an increase of 8.97% compared to the previous year's 1.83 billion. Earnings were 305.64 million, an increase of 88.54%.